Neural Circuit Delineation of (±)-3,4-methylenedioxymethamphetamine (MDMA)-evoked Sociability and Fear Memory Deficits

被引：0
|
作者：
Casey, Austen [1 ]
Rijsketic, Daniel Ryskamp [1 ]
Zhao, Wesley [1 ]
Palmer, Alexander [1 ]
Salgado, Juliana [1 ]
Llorach, Pierre [1 ]
Wall, Nicholas [1 ]
Pomrenze, Matthew [1 ]
Malenka, Robert [1 ]
Heifets, Boris [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA USA
来源：
BIOLOGICAL PSYCHIATRY | 2024年 / 95卷 / 10期
关键词：
c-fos; PTSD - Posttraumatic Stress Disorder; Sociability; Memory Processing; MDMA;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
378
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [41] Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature
    Drevin, Guillaume
    Pena-Martin, Maria
    Bauduin, Aurelien
    Baudriller, Antoine
    Briet, Marie
    Abbara, Chadi
    [J]. PHARMACEUTICS, 2024, 16 (08)
  • [42] 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
    M B Young
    R Andero
    K J Ressler
    L L Howell
    [J]. Translational Psychiatry, 2015, 5 : e634 - e634
  • [43] 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
    Young, M. B.
    Andero, R.
    Ressler, K. J.
    Howell, L. L.
    [J]. TRANSLATIONAL PSYCHIATRY, 2015, 5 : e634 - e634
  • [44] Cyclophilin D is implicated in the cognitive deficits and serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in mice
    Mouri, Akihiro
    Noda, Yukihiro
    Shimizu, Shigeomi
    Tsujimoto, Yoshihide
    Nabeshima, Toshitaka
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 219P - 219P
  • [45] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    [J]. PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [46] The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)
    Cole, JC
    Sumnall, HR
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (03): : 199 - 217
  • [47] 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY'): GENDER DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS
    Pardo-Lozano, R.
    Farre, M.
    Yubero-Lahoz, S.
    Torrens, M.
    Mustata, C.
    Perez-Mana, C.
    Menoyo, E.
    Perez, M.
    Martin, S.
    Cuyas, E.
    Civit, E.
    O'Mathuna, B.
    Carbo, M.
    de la Torre, R.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 51 - 52
  • [48] 3,4-methylenedioxymethamphetamine (MDMA) intoxication in an infant chronically exposed to cocaine
    Garcia-Algar, O
    López, N
    Bonet, M
    Pellegrini, M
    Marchei, E
    Pichini, S
    [J]. THERAPEUTIC DRUG MONITORING, 2005, 27 (04) : 409 - 411
  • [49] α-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity
    Aguirre, N
    Barrionuevo, M
    Ramírez, MJ
    Del Río, J
    Lasheras, B
    [J]. NEUROREPORT, 1999, 10 (17) : 3675 - 3680
  • [50] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
    Cohen, RS
    Cocores, J
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04): : 727 - 734
12345